NO20035732L - Diagnostiske analyser for parvovirus B19 - Google Patents

Diagnostiske analyser for parvovirus B19

Info

Publication number
NO20035732L
NO20035732L NO20035732A NO20035732A NO20035732L NO 20035732 L NO20035732 L NO 20035732L NO 20035732 A NO20035732 A NO 20035732A NO 20035732 A NO20035732 A NO 20035732A NO 20035732 L NO20035732 L NO 20035732L
Authority
NO
Norway
Prior art keywords
parvovirus
diagnostic analyzes
primers
analyzes
diagnostic
Prior art date
Application number
NO20035732A
Other languages
English (en)
Other versions
NO20035732D0 (no
NO337901B1 (no
Inventor
Sergio Pichuantes
Venkatakrishna Shyamala
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO20035732D0 publication Critical patent/NO20035732D0/no
Publication of NO20035732L publication Critical patent/NO20035732L/no
Publication of NO337901B1 publication Critical patent/NO337901B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Abstract

Sammendrag Humant parvovirus-B 19-primere og prober utledet fra konserverte regioner i parvovirus-B 19-genomet beskrives. Også nukleinsyrebaserte analyser som anvender primerne og probene beskrives.
NO20035732A 2001-06-28 2003-12-19 Diagnostiske analyser for parvovirus B19 NO337901B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30207701P 2001-06-28 2001-06-28
US36595602P 2002-03-19 2002-03-19
US36922402P 2002-03-29 2002-03-29
PCT/US2002/020684 WO2003002753A2 (en) 2001-06-28 2002-06-28 Diagnostic assays for parvovirus b19

Publications (3)

Publication Number Publication Date
NO20035732D0 NO20035732D0 (no) 2003-12-19
NO20035732L true NO20035732L (no) 2004-02-27
NO337901B1 NO337901B1 (no) 2016-07-04

Family

ID=28794978

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035732A NO337901B1 (no) 2001-06-28 2003-12-19 Diagnostiske analyser for parvovirus B19

Country Status (20)

Country Link
US (2) US6936442B2 (no)
EP (1) EP1537235B1 (no)
JP (5) JP2005511004A (no)
KR (2) KR100944674B1 (no)
CN (1) CN1324147C (no)
AU (2) AU2002318450B2 (no)
BG (1) BG66283B1 (no)
BR (1) BRPI0211191B8 (no)
CA (2) CA2779653C (no)
CZ (1) CZ308201B6 (no)
ES (1) ES2537549T3 (no)
HK (1) HK1080516B (no)
HU (1) HU230244B1 (no)
MX (1) MXPA03011802A (no)
NO (1) NO337901B1 (no)
NZ (1) NZ530602A (no)
PL (1) PL210849B1 (no)
RU (1) RU2301263C2 (no)
SK (1) SK15752003A3 (no)
WO (1) WO2003002753A2 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1421095B1 (en) * 2001-08-31 2013-10-09 Gen-Probe Incorporated Assay for detection of human parvovirus b19 nucleic acid
US20120122099A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
WO2005071401A2 (en) * 2004-01-15 2005-08-04 Chiron Corporation Homogeneous multiplex assay for nucleic acid targets
EP1799856A4 (en) * 2004-09-10 2009-03-04 Focus Diagnostics Inc METHOD AND COMPOSITIONS FOR DETECTING ERYTHROVIRUS GENOTYPES
CA2582661C (en) * 2004-11-09 2015-08-11 Gen-Probe Incorporated Compositions and methods for detecting group a streptococci
US8058000B2 (en) 2005-06-02 2011-11-15 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
US7572584B2 (en) * 2005-06-02 2009-08-11 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
JP2010516231A (ja) * 2007-01-16 2010-05-20 タレクリス バイオセラピューティクス，インコーポレーテッド ヒトエリスロウイルス
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN101815528A (zh) * 2007-06-14 2010-08-25 俄克拉荷马州大学评议会 包含犬细小病毒遗传性变体的疫苗
US20110045456A1 (en) * 2007-06-14 2011-02-24 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
JP2011521255A (ja) * 2008-07-23 2011-07-21 インダストリー−アカデミック コーオペレーション ファンデーション キョンサン ナショナル ユニバーシティ ウイルス診断方法及びシステム
AU2010217928B2 (en) 2009-02-26 2013-06-06 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
US9598739B1 (en) 2009-03-13 2017-03-21 Grifols Therapeutics Inc. Human erythrovirus
WO2011127316A1 (en) * 2010-04-07 2011-10-13 Novartis Ag Method for generating a parvovirus b19 virus-like particle
ES2945966T3 (es) * 2011-07-15 2023-07-11 Gen Probe Inc Composiciones y procedimiento para detectar ácido nucleico del parvovirus humano y ácido nucleico del virus de la hepatitis A
CN103451320B (zh) * 2013-08-09 2015-05-06 中国人民解放军军事医学科学院野战输血研究所 人细小病毒B19三种基因型的实时荧光定量PCR检测方法及其通用检测引物、TaqMan探针与试剂盒
US9410172B2 (en) * 2013-09-16 2016-08-09 General Electric Company Isothermal amplification using oligocation-conjugated primer sequences
WO2015138424A1 (en) 2014-03-10 2015-09-17 University Of Louisville Research Foundaton, Inc. Compositions and methods for treating, including preventing, parvovirus infections and related diseases
CN103820581B (zh) * 2014-03-17 2016-01-13 成都蓉生药业有限责任公司 一种检测人细小病毒b19的试剂盒和方法
JP6414409B2 (ja) * 2014-07-29 2018-10-31 株式会社微生物化学研究所 弱毒化パルボウイルスおよび弱毒化パルボウイルスを用いたワクチン
US20180155798A1 (en) * 2014-11-05 2018-06-07 Indian Council Of Medical Research In-Vitro Detection of Human Parvovirus 4
TW202336236A (zh) * 2015-03-27 2023-09-16 美商再生元醫藥公司 偵測生物污染物之組成物及方法
CN105158471A (zh) * 2015-08-24 2015-12-16 北京中检安泰诊断科技有限公司 人细小病毒B19型IgM抗体检测试剂盒及其制备方法
CN114410836B (zh) * 2021-12-17 2024-03-01 上海交通大学医学院附属仁济医院 一种集样本处理、核酸提取及多重恒温扩增一体化的检测人细小病毒b19的试剂盒和方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516630A (en) 1983-09-30 1996-05-14 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting hepatitis A virus
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US6287815B1 (en) * 1989-09-14 2001-09-11 Rijksuniversiteit Te Leiden Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
NL8902301A (nl) 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
US6204044B1 (en) * 1989-09-14 2001-03-20 Caroline Sarah Brown Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
DE4003826C2 (de) 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
WO1994010294A1 (en) 1992-10-23 1994-05-11 New York University Human monoclonal antibodies to human parvovirus and methods of making and using thereof
US5449608A (en) 1993-03-22 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Parvovirus B19 receptor and parvovirus B19 detection
JPH06293798A (ja) 1993-04-06 1994-10-21 Shin Etsu Chem Co Ltd ヒトパルボウイルスｂ１９のエピトープ関連ペプチド
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0783580A2 (en) 1994-09-22 1997-07-16 Wolf, Hans Joachim Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
US6004044A (en) * 1995-05-03 1999-12-21 Itt Cannon, Inc. Optoelectric connector
JPH0910000A (ja) 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya ヒトパルボウイルスの検出方法及びそのための試薬
HU226469B1 (en) * 1995-11-13 2008-12-29 Shionogi & Co Process and kit for diagnosis of diseases associated with coronary twitching
WO1997021346A1 (en) 1995-12-14 1997-06-19 Cerus Corporation Inactivation of non-enveloped virus
US6094338A (en) * 1997-07-09 2000-07-25 Mitsubishi Chemical Corporation Electric double-layer capacitor
AU1269699A (en) 1997-10-08 1999-04-27 Advanced Research And Technology Institute, Inc. Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage
DE19752898A1 (de) 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
CA2318880C (en) * 1998-02-04 2010-07-27 Perkin-Elmer Corporation Determination of a genotype of an amplification product at multiple allelic sites
RU2146372C1 (ru) * 1998-04-16 2000-03-10 Гематологический научный центр РАМН Способ определения парвовируса б19
US6238860B1 (en) * 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6642033B1 (en) * 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
DE60022541T2 (de) * 1999-07-23 2006-06-14 Gen Probe Inc Polynukleotid- amplifikationsverfahren

Also Published As

Publication number Publication date
HK1080516B (zh) 2008-01-25
BRPI0211191B8 (pt) 2021-07-27
KR100888377B1 (ko) 2009-03-13
AU2007231822A1 (en) 2007-11-29
US20030170612A1 (en) 2003-09-11
HUP0600779A3 (en) 2010-03-29
HUP0600779A2 (en) 2007-01-29
MXPA03011802A (es) 2004-04-02
SK15752003A3 (sk) 2005-01-03
CA2779653A1 (en) 2003-01-09
RU2301263C2 (ru) 2007-06-20
AU2007231822B2 (en) 2011-01-27
JP6026401B2 (ja) 2016-11-16
WO2003002753A3 (en) 2005-04-14
JP2016182149A (ja) 2016-10-20
EP1537235B1 (en) 2015-04-01
BG66283B1 (bg) 2013-01-31
KR20090003370A (ko) 2009-01-09
HK1080516A1 (en) 2006-04-28
BR0211191A (pt) 2006-05-23
BG108526A (bg) 2004-09-30
ES2537549T3 (es) 2015-06-09
PL368049A1 (en) 2005-03-21
JP2005511004A (ja) 2005-04-28
EP1537235A4 (en) 2007-10-03
NO20035732D0 (no) 2003-12-19
NZ530602A (en) 2006-02-24
PL210849B1 (pl) 2012-03-30
CA2451756A1 (en) 2003-01-09
CN1636071A (zh) 2005-07-06
CA2779653C (en) 2014-08-19
BRPI0211191B1 (pt) 2015-09-15
CN1324147C (zh) 2007-07-04
KR20050119220A (ko) 2005-12-21
JP2014061007A (ja) 2014-04-10
JP2012075440A (ja) 2012-04-19
EP1537235A2 (en) 2005-06-08
WO2003002753A2 (en) 2003-01-09
US6936442B2 (en) 2005-08-30
HU230244B1 (hu) 2015-11-30
KR100944674B1 (ko) 2010-03-04
NO337901B1 (no) 2016-07-04
AU2002318450B2 (en) 2007-11-22
CZ20033516A3 (cs) 2005-02-16
RU2004102205A (ru) 2005-06-10
CZ308201B6 (cs) 2020-02-26
JP2009011324A (ja) 2009-01-22
US20050221300A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
NO20035732L (no) Diagnostiske analyser for parvovirus B19
IL258545B (en) Recombinant aav viruses, a method for their creation and uses
NO20032559L (no) Gripeklosammenstilling for endoskopiske instrument
DK0759927T3 (da) Pteridinnucleotidanaloger som fluorescerende DNA prober
DE60226797D1 (de) Instrument zum Einbringen von Befestigungselementen für Transplantate
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
YU40701A (sh) Piperidini kao modulatori ccr5
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
ATE550099T1 (de) Verbessertes system für mehrfarbige echtzeit-pcr
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
ATE338550T1 (de) Mikronisierter zolpidem hemitartrat
HUP0301581A2 (hu) Sejteken prezentált peptidek
DE60026150D1 (de) Diagnostika und therapeutika für osteoporose
ATE346958T1 (de) Universelles nachweissystem für mehrere varianten
DE69637640D1 (de) N und anwendungen
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
DK1565573T3 (da) Nukleinsyreprober og bredspektrede primere fra regioner i topoisomerasegener samt fremgangsmåder hvori de anvendes
NO20002408L (no) 5-HT1F antagonister
FI20010323A0 (fi) Diagnostinen geenitesti
ES1052893Y (es) Instrumento de gimnasia de balanceo.
DE602004028862D1 (de) Der nukleinsäuren von hiv-1 und hiv-2
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
Evans The Implications of the Central Negligence Scheme for trusts on Midwifery Practice and Knowledge.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GRIFOLS WORLDWIDE OPERATIONS LIMITED, IE

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE

MM1K Lapsed by not paying the annual fees